Structures by: Portilla J.
Total: 82
2-(4-(4-Methoxyphenyl)-3-methyl-1-phenylindeno[1,2-b]pyrazolo[4,3-e]pyridin-5(1H)-ylidene)malononitrile'
C30H19N5O
RSC Advances (2019) 9, 47 27318
a=14.878(7)Å b=12.149(6)Å c=27.262(12)Å
α=90° β=96.052(12)° γ=90°
7-(4-Chlorophenyl)-3-iodo-2-methylpyrazolo[1,5-a]pyrimidine
C13H9ClIN3
RSC Adv. (2017) 7, 45 28483
a=8.1315(6)Å b=12.4851(8)Å c=14.5014(7)Å
α=105.748(5)° β=105.605(6)° γ=99.832(6)°
1,3,5-tris(2-(tert-Butyl)pyrazolo[1,5-a]pyrimidin-7-yl)benzene
C150H162N36
RSC Adv. (2017) 7, 45 28483
a=14.6829(3)Å b=14.6829(3)Å c=57.9972(11)Å
α=90° β=90° γ=120°
4-(4-Chlorophenyl)-2-methyl-1<i>H</i>-imidazole hemihydrate
C10H9Cl1N2,0.5(H2O1)
Acta Crystallographica Section C (2018) 74, 11
a=10.4027(15)Å b=18.093(2)Å c=11.1496(16)Å
α=90° β=101.573(14)° γ=90°
2-Methyl-4-phenyl-1<i>H</i>-imidazole
C10H10N2
Acta Crystallographica Section C (2018) 74, 11
a=29.196(4)Å b=29.196(4)Å c=5.4212(10)Å
α=90° β=90° γ=120°
4-(4-Methoxyphenyl)-2-methyl-1<i>H</i>-imidazole
C11H12N2O
Acta Crystallographica Section C (2018) 74, 11
a=7.1530(11)Å b=7.4824(14)Å c=21.437(3)Å
α=90° β=90° γ=90°
(<i>E</i>)-1-<i>tert</i>-Butyl-5-[(2,4-dichlorobenzylidene)amino]-1<i>H</i>-pyrrole-3-carbonitrile
C16H15Cl2N3
Acta Crystallographica Section C (2018) 74, 1 82-93
a=6.5428(7)Å b=7.9586(11)Å c=30.415(5)Å
α=90° β=92.987(13)° γ=90°
(<i>E</i>)-1-<i>tert</i>-butyl-5-[(4-chlorobenzylidene)amino]-1<i>H</i>-pyrrole-3-carbonitrile
C16H16ClN3
Acta Crystallographica Section C (2018) 74, 1 82-93
a=8.8317(14)Å b=24.261(3)Å c=6.9706(14)Å
α=90° β=90° γ=90°
(<i>E</i>)-1-<i>tert</i>-Butyl-5-[(pyridin-4-ylmethylene)amino]-1<i>H</i>-pyrrole-3-carbonitrile
C15H16N4
Acta Crystallographica Section C (2018) 74, 1 82-93
a=8.1494(8)Å b=9.0629(10)Å c=9.4859(9)Å
α=92.465(8)° β=97.113(8)° γ=97.136(9)°
1-<i>tert</i>-Butyl-5-[(2,4-dichlorobenzyl)amino]-1<i>H</i>-pyrrole-3-carbonitrile
C16H17Cl2N3
Acta Crystallographica Section C (2018) 74, 1 82-93
a=8.9700(12)Å b=9.3244(12)Å c=10.4645(14)Å
α=105.057(12)° β=103.589(12)° γ=95.078(11)°
1-<i>tert</i>-Butyl-5-[(4-chlorobenzyl)amino]-1<i>H</i>-pyrrole-3-carbonitrile
C16H18ClN3
Acta Crystallographica Section C (2018) 74, 1 82-93
a=8.2422(10)Å b=9.2361(10)Å c=20.623(2)Å
α=90° β=98.521(11)° γ=90°
C18H14Cl2N2O
C18H14Cl2N2O
Acta Crystallographica Section B (2019) 75, 6
a=11.351(3)Å b=16.259(6)Å c=9.589(3)Å
α=90° β=107.41(3)° γ=90°
C18H14F2N2O
C18H14F2N2O
Acta Crystallographica Section B (2019) 75, 6
a=11.984(3)Å b=9.537(2)Å c=26.808(7)Å
α=90° β=90° γ=90°
C18H12Cl4N2O
C18H12Cl4N2O
Acta Crystallographica Section B (2019) 75, 6
a=4.4932(5)Å b=10.9707(11)Å c=18.786(2)Å
α=76.483(9)° β=83.305(9)° γ=78.976(9)°
8-methyl-7-(4-chlorophenyl)-10-phenyl-6,10-dihydro- 5H-benzo[h]pyrazolo[3,4-b]quinoline
C27H20ClN3
Acta Crystallographica Section B (2008) 64, 1 72-83
a=12.1072(4)Å b=14.2672(5)Å c=12.7635(4)Å
α=90.00° β=109.953(8)° γ=90.00°
8-methyl-7-(3-pyridinyl)-10-phenyl-6,10- dihydro-5H-benzo[h]pyrazolo[3,4-b]quinoline
C26H20N4
Acta Crystallographica Section B (2008) 64, 1 72-83
a=11.2274(6)Å b=13.7079(8)Å c=12.6935(7)Å
α=90.00° β=95.731(3)° γ=90.00°
11-(3,4,5-trimethoxyphenyl)-10-methyl-8-phenyl-6,8- dihydro-5H-benzo[f]pyrazolo[3,4-b]quinoline
C30H27N3O3
Acta Crystallographica Section B (2008) 64, 1 72-83
a=10.4716(9)Å b=20.0027(18)Å c=12.1529(9)Å
α=90.00° β=107.818(4)° γ=90.00°
8-methyl-7-(4-pyridinyl)-10-phenyl-10H- benzo[h]pyrazolo[3,4-b]quinoline
C26H18N4
Acta Crystallographica Section B (2008) 64, 1 72-83
a=11.3560(3)Å b=17.3507(5)Å c=9.7577(2)Å
α=90.00° β=97.262(2)° γ=90.00°
11-(4-methoxyphenyl)-10-methyl-8-phenyl-6,8-dihydro- 5H-benzo[f]pyrazolo[3,4-b]quinoline
C28H23N3O
Acta Crystallographica Section B (2008) 64, 1 72-83
a=18.0854(3)Å b=21.2296(5)Å c=23.8007(5)Å
α=90.00° β=108.2580(10)° γ=90.00°
11-(4-methylphenyl)-10-methyl-8-phenyl-6,8-dihydro- 5H-benzo[f]pyrazolo[3,4-b]quinoline
C28H23N3
Acta Crystallographica Section B (2008) 64, 1 72-83
a=11.1334(3)Å b=11.4672(2)Å c=17.6270(4)Å
α=97.858(2)° β=106.135(3)° γ=97.496(2)°
5-Butylamino-3-methyl-1-(pyridin-2-yl)-1<i>H</i>-pyrazole-4-carbaldehyde
C14H18N4O
Acta Crystallographica Section E (2016) 72, 11 1672-1674
a=9.2854(2)Å b=7.59144(18)Å c=19.4452(5)Å
α=90° β=102.818(3)° γ=90°
Bis-(5-amino-3-methyl-1-phenyl-1H-pyrazol-4-yl)-3,4,5-trimethoxyphenylmethane
C30H32N6O3
Acta Crystallographica Section E (2004) 60, 6 o1034-o1037
a=9.7540(2)Å b=33.4646(7)Å c=8.90100(10)Å
α=90.00° β=103.6020(9)° γ=90.00°
3,5-Dimethyl-1,7-diphenyl-1,7-dihydrodipyrazolo[3,4-b,4',3'-e]pyridine
C21H17N5
Acta Crystallographica Section E (2006) 62, 5 o1676-o1678
a=21.2976(4)Å b=10.9267(3)Å c=7.4201(2)Å
α=90.00° β=98.108(2)° γ=90.00°
3,5-Dimethyl-1,7-diphenyl-4-(2-pyridinyl)-1H,7H-pyrazolo[3,4-b:4',3'-e]pyridine
C26H20N6
Acta Crystallographica Section E (2003) 59, 9 o1327-o1329
a=8.4576(2)Å b=10.6599(3)Å c=12.3642(4)Å
α=106.9170(14)° β=98.6240(16)° γ=100.803(2)°
3,5-Dimethyl-1,4,7-triphenyl-1H,7H-pyrazolo[3,4-b:4',3'-e]pyridine
C27H21N5
Acta Crystallographica Section E (2003) 59, 9 o1330-o1331
a=8.5006(2)Å b=10.5829(3)Å c=12.4093(3)Å
α=106.0775(12)° β=97.6152(15)° γ=100.6751(10)°
1-(p-Chlorophenyl)-3,4-dimethyl-5,6,7,8-tetrahydropyrazolo[3,4-b]quinoline
C18H18ClN3
Acta Crystallographica Section E (2003) 59, 11 o1657-o1658
a=10.2097(6)Å b=7.5773(3)Å c=20.6921(12)Å
α=90.00° β=110.203(3)° γ=90.00°
6-(2-Hydroxybenzoyl)-2-(4-methylphenyl)-5-methyl-7- phenylpyrazolo[1,5-a]pyrimidine
C27H21N3O2
Acta Crystallographica Section E (2006) 62, 8 o3195-o3197
a=38.7649(11)Å b=6.7864(2)Å c=16.7002(5)Å
α=90.00° β=108.599(2)° γ=90.00°
8-tert-Butyl-7,10-diphenyl-6,10-dihydro-5H-benzo[h]pyrazolo[3,4-b]quinoline
C30H27N3
Acta Crystallographica Section E (2007) 63, 5 o2690-o2691
a=9.516(2)Å b=10.406(3)Å c=11.868(5)Å
α=99.52(4)° β=100.42(2)° γ=91.55(4)°
N,N'-Bis(isonicotinoyl)hydrazine dihydrate
C12H10N4O2,2H2O
Acta Crystallographica Section E (2007) 63, 4 o1687-o1690
a=28.1492(15)Å b=24.1628(13)Å c=3.7181(5)Å
α=90.00° β=90.00° γ=90.00°
5-Cyclohexylamino-3-methyl-1-(pyridin-2-yl)-1<i>H</i>-pyrazole-4-carbaldehyde
C16H20N4O
Acta Crystallographica Section C (2015) 71, 5
a=21.369(2)Å b=20.489(3)Å c=6.7444(10)Å
α=90° β=95.978(10)° γ=90°
(<i>Z</i>)-4-[(Cyclohexylamino)methylidene]-3-methyl-1-phenyl-1<i>H</i>-pyrazol-5(4<i>H</i>)-one
C17H21N3O
Acta Crystallographica Section C (2015) 71, 5
a=7.3348(3)Å b=7.3614(10)Å c=29.2335(6)Å
α=91.243(3)° β=92.678(10)° γ=101.004(4)°
10-methyl-8-phenyl-11-(3-pyridyl)-6,8-dihydro-5H- benzo[f]pyrazolo[3,4-b]quinoline
C26H20N4
Acta Crystallographica Section C (2005) 61, 8 o490-o492
a=19.2181(6)Å b=19.2181(6)Å c=10.8347(2)Å
α=90.00° β=90.00° γ=90.00°
10-methyl-8-phenyl-11-(4-pyridyl)-6,8-dihydro-5H- benzo[f]pyrazolo[3,4-b]quinoline
C26H20N4
Acta Crystallographica Section C (2005) 61, 8 o490-o492
a=18.6288(8)Å b=19.1956(8)Å c=10.8885(3)Å
α=90.00° β=90.00° γ=90.00°
5-methyl-2-(4-methylphenyl)-7,8-dihydro-6H- cyclopenta[g]pyrazolo[1,5-a]pyrimidine
C17H17N3
Acta Crystallographica Section C (2005) 61, 7 o452-o456
a=13.2882(7)Å b=6.8383(4)Å c=15.1947(8)Å
α=90.00° β=104.018(3)° γ=90.00°
2-(4-chlorophenyl)-5-methyl-7,8-dihydro-6H- cyclopenta[g]pyrazolo[1,5-a]pyrimidine
C16H14ClN3
Acta Crystallographica Section C (2005) 61, 7 o452-o456
a=13.6800(11)Å b=6.6669(6)Å c=15.2010(16)Å
α=90.00° β=106.980(6)° γ=90.00°
(4-methoxyphenyl)-5-methyl- 7,8-dihydro-6H-cyclopenta[g]pyrazolo[1,5-a]pyrimidine
C17H17N3O
Acta Crystallographica Section C (2005) 61, 7 o452-o456
a=9.4691(3)Å b=8.1711(2)Å c=18.0278(6)Å
α=90.00° β=95.3430(14)° γ=90.00°
8-methyl-10-phenyl-6,10-dihydro-5H-benzo[h]pyrazolo[3,4-b]quinoline
C21H17N3
Acta Crystallographica Section C (2005) 61, 8 o483-o489
a=7.0870(2)Å b=10.1321(4)Å c=11.7977(5)Å
α=87.501(2)° β=73.171(3)° γ=74.828(2)°
8-methyl-7,10-diphenyl-6,10-dihydro-5H-benzo[h]pyrazolo[3,4-b]quinoline
C27H21N3
Acta Crystallographica Section C (2005) 61, 8 o483-o489
a=11.5561(4)Å b=17.6751(7)Å c=9.8469(3)Å
α=90.00° β=98.599(2)° γ=90.00°
8-methyl-7-(4-methylphenyl)-10-phenyl-6,10-dihydro-5H- benzo[h]pyrazolo[3,4-b]quinoline
C28H23N3
Acta Crystallographica Section C (2005) 61, 8 o483-o489
a=12.0313(3)Å b=14.3347(4)Å c=12.7956(3)Å
α=90.00° β=109.3092(14)° γ=90.00°
7-(4-methoxyphenyl)-8-methyl-10-phenyl-6,10-dihydro-5H- benzo[h]pyrazolo[3,4-b]quinoline
C28H23N3O
Acta Crystallographica Section C (2005) 61, 8 o483-o489
a=12.9148(3)Å b=17.5938(5)Å c=9.8192(2)Å
α=90.00° β=104.3370(17)° γ=90.00°
2-(4-bromophenyl)-5-methyl-7,8-dihydro-6H- cyclopenta[g]pyrazolo[1,5-a]pyrimidine
C16H14BrN3
Acta Crystallographica Section C (2005) 61, 7 o452-o456
a=13.5387(6)Å b=6.8551(2)Å c=15.2767(7)Å
α=90.00° β=105.708(2)° γ=90.00°
(3<i>Z</i>)-3-{1-[(5-phenyl-1<i>H</i>-pyrazol-3-yl)amino]ethylidene}-4,5- dihydrofuran-2(3<i>H</i>)-one
C15H15N3O2
Acta Crystallographica Section C (2010) 66, 1 o25-o28
a=10.4969(17)Å b=9.8550(9)Å c=12.6739(16)Å
α=90.00° β=99.883(9)° γ=90.00°
(3<i>Z</i>)-3-{1-[(5-methyl-1<i>H</i>-pyrazol-3-yl)amino]ethylidene}-4,5- dihydrofuran-2(3<i>H</i>)-one--6-(2-hydroxyethyl)-2,5- dimethylpyrazolo[1,5-<i>a</i>]pyrimidin-7(4<i>H</i>)-one (1/1)
C10H13N3O2,C10H13N3O2
Acta Crystallographica Section C (2010) 66, 1 o25-o28
a=8.0402(11)Å b=8.2025(17)Å c=15.348(3)Å
α=91.999(14)° β=99.785(12)° γ=99.172(15)°
7-Amino-2,5-dimethylpyrazolo[1,5-a]pyrimidine hemihydrate
C8H10N4,0.5H2O
Acta Crystallographica Section C (2006) 62, 4 o186-o189
a=16.0851(5)Å b=7.9458(3)Å c=8.0003(3)Å
α=90.00° β=117.309(2)° γ=90.00°
3-(3-Oxo-1,3-dihydroisobenzofuran-1-ylidene)pentane-2,4-dione
C13H10O4
Acta Crystallographica Section C (2007) 63, 6 o332-o333
a=8.2779(3)Å b=8.4719(6)Å c=15.1413(12)Å
α=90.0° β=95.534(6)° γ=90.0°
8-<i>tert</i>-Butyl-7-(4-chlorophenyl)-10-phenyl-5,6-dihydro-10<i>H</i>- benzo[<i>h</i>]pyrazolo[3,4-<i>b</i>]quinoline
C30H26ClN3
Acta Crystallographica Section C (2007) 63, 10 o582-o584
a=13.1170(18)Å b=15.948(3)Å c=17.717(2)Å
α=93.750(11)° β=91.803(9)° γ=101.155(13)°
7-Amino-5-methyl-2-phenyl-6-(phenyldiazenyl)pyrazolo[1,5-<i>a</i>]pyrimidine
C19H16N6
Acta Crystallographica Section C (2010) 66, 3 o133-o136
a=9.6342(13)Å b=33.216(5)Å c=9.747(3)Å
α=90.00° β=90.237(18)° γ=90.00°
9-(4-Chlorophenyl)-7-methyl-5,6-dihydrobenzo[h]pyrazolo[3,2-b]quinazoline
C21H16ClN3
Acta Crystallographica Section C (2004) 60, 8 o604-o607
a=9.2382(8)Å b=10.3054(8)Å c=10.3184(9)Å
α=62.720(4)° β=83.098(4)° γ=70.531(5)°
2-(4-Chlorophenyl)-5-methyl-6,7-dihydrobenzo[e]pyrazolo[2,3-b]quinazoline
C21H16ClN3
Acta Crystallographica Section C (2004) 60, 8 o604-o607
a=7.0098(3)Å b=15.0306(7)Å c=17.0060(8)Å
α=111.492(2)° β=101.406(3)° γ=97.981(3)°
5-Methyl-<i>N</i>-[2-nitro-4-(trifluoromethyl)phenyl]-1<i>H</i>-pyrazole- 3-amine
C11H9F3N4O2
Acta Crystallographica Section C (2013) 69, 2 172-174
a=4.957(2)Å b=8.737(3)Å c=13.562(5)Å
α=93.22(3)° β=97.02(3)° γ=91.05(3)°
5-Amino-1-benzoyl-3-methylpyrazole
C11H11N3O
Acta Crystallographica Section C (2010) 66, 4 o159-o162
a=14.7443(6)Å b=5.7669(2)Å c=12.0082(3)Å
α=90.00° β=106.119(2)° γ=90.00°
Ethyl 4-(5-amino-3-methyl-1H-pyrazol-1-yl)benzoate
C13H15N3O2
Acta Crystallographica Section C (2007) 63, 1 o21-o25
a=7.2228(4)Å b=8.4433(3)Å c=10.5938(5)Å
α=98.234(3)° β=107.609(2)° γ=97.907(3)°
4-(5-Amino-3-methyl-1H-pyrazol-1-yl)benzoic acid monohydrate
C11H11N3O2,H2O
Acta Crystallographica Section C (2007) 63, 1 o21-o25
a=8.0166(2)Å b=7.5082(2)Å c=18.5507(5)Å
α=90.00° β=91.8140(16)° γ=90.00°
7-Amino-2-tert-butyl-5-methylpyrazolo[1,5-a]pyrimidine
C11H16N4
Acta Crystallographica Section C (2007) 63, 1 o26-o28
a=10.8271(2)Å b=10.8271(2)Å c=19.9208(3)Å
α=90.00° β=90.00° γ=90.00°
Methyl 4-[(5-methyl-1H-pyrazol-3-yl)amino]-3-nitrobenzoate
C12H12N4O4
Acta Crystallographica Section C (2007) 63, 1 o38-o41
a=5.9233(3)Å b=8.8858(6)Å c=11.7819(6)Å
α=85.690(4)° β=83.500(4)° γ=84.015(3)°
Methyl 1-(5-methyl-1H-pyrazol-3-yl)-1H-benzimidazole-5-carboxylate
C13H12N4O2
Acta Crystallographica Section C (2007) 63, 1 o38-o41
a=8.3646(3)Å b=11.5735(6)Å c=12.7953(7)Å
α=88.328(3)° β=88.526(3)° γ=75.362(3)°
7-amino-5-tert-butyl-2-methylpyrazolo[1,5-a]pyrimidine
C11H16N4
Acta Crystallographica Section C (2006) 62, 8 o521-o524
a=9.8216(5)Å b=11.3582(7)Å c=12.2783(8)Å
α=70.429(3)° β=69.895(4)° γ=66.454(4)°
3,7-diamino-2,5-dimethylpyrazolo[1,5-a]pyrimidine monohydrate
C8H11N5,H2O
Acta Crystallographica Section C (2006) 62, 8 o521-o524
a=8.0970(2)Å b=9.8881(3)Å c=11.9661(3)Å
α=90.00° β=96.230(5)° γ=90.00°
2,5-Dimethyl-6,7-dihydrobenzo[h]pyrazolo[1,5-a]quinazoline
C16H15N3
Acta Crystallographica Section C (2007) 63, 8 o458-o461
a=7.9430(19)Å b=7.9660(11)Å c=9.943(3)Å
α=87.637(13)° β=82.632(18)° γ=89.941(17)°
2-tert-Butyl-5-methyl-6,7-dihydrobenzo[h]pyrazolo[1,5-a]quinazoline
C19H21N3
Acta Crystallographica Section C (2007) 63, 8 o458-o461
a=11.2632(5)Å b=11.4574(7)Å c=12.1317(6)Å
α=93.449(5)° β=90.313(4)° γ=102.791(6)°
Methyl 4-(5-amino-3-phenyl-1<i>H</i>-pyrazol-1-yl)-3-nitrobenzoate
C17H14N4O4
Acta Crystallographica Section C (2007) 63, 9 o510-o513
a=12.3516(8)Å b=7.5202(4)Å c=17.1564(13)Å
α=90.00° β=100.699(5)° γ=90.00°
Methyl 3-nitro-4-[(5-phenyl-1<i>H</i>-pyrazol-3-yl)amino]benzoate
C17H14N4O4
Acta Crystallographica Section C (2007) 63, 9 o510-o513
a=31.0506(4)Å b=5.4210(11)Å c=20.7251(12)Å
α=90.00° β=121.071(6)° γ=90.00°
5-Amino-1-(4-methoxybenzoyl)-3-methylpyrazole
C12H13N3O2
Acta Crystallographica Section C (2008) 64, 2 o76-o79
a=6.1920(15)Å b=9.192(2)Å c=10.546(2)Å
α=73.69(2)° β=85.634(17)° γ=82.83(3)°
5-Amino-3-methyl-1-(2-nitrobenzoyl)pyrazole
C11H10N4O3
Acta Crystallographica Section C (2008) 64, 2 o76-o79
a=11.4212(15)Å b=7.1787(14)Å c=13.2595(10)Å
α=90.00° β=90.00° γ=90.00°
5-methyl-2-phenyl-6,7-dihydrobenzo[h]pyrazolo[1,5-a]quinazoline
C21H17N3
Acta Crystallographica Section C (2005) 61, 6 o398-o403
a=7.6223(2)Å b=16.7937(7)Å c=24.4900(9)Å
α=90.00° β=90.00° γ=90.00°
5-methyl-2-(4-methylphenyl)-6,7-dihydrobenzo[h]pyrazolo[1,5-a]quinazoline
C22H19N3
Acta Crystallographica Section C (2005) 61, 6 o398-o403
a=7.2767(13)Å b=29.924(6)Å c=8.0463(12)Å
α=90.00° β=112.590(6)° γ=90.00°
7-methyl-10-phenyl-5,6-dihydrobenzo[h]pyrazolo[5,1-b]quinazoline
C21H17N3
Acta Crystallographica Section C (2005) 61, 6 o398-o403
a=8.10920(10)Å b=11.7265(2)Å c=16.3486(3)Å
α=90.00° β=90.9010(12)° γ=90.00°
7-methyl-10-(4-methylphenyl)-5,6-dihydrobenzo[h]pyrazolo[5,1-b]quinazoline
C22H19N3
Acta Crystallographica Section C (2005) 61, 6 o398-o403
a=7.9037(7)Å b=13.1038(10)Å c=16.0576(13)Å
α=90.00° β=99.199(6)° γ=90.00°
2-<i>tert</i>-Butyl-5-methyl-7,8-dihydro-6<i>H</i>- cyclopenta[<i>e</i>]pyrazolo[1,5-<i>a</i>]pyrimidine
C14H19N3
Acta Crystallographica Section C (2008) 64, 9 o471-o473
a=6.8665(6)Å b=9.4084(14)Å c=11.147(2)Å
α=91.611(14)° β=107.728(14)° γ=111.097(12)°
3-<i>tert</i>-butyl-1-(4-chlorophenyl)-4- phenylindeno[1,2-<i>b</i>]pyrazolo[4,3-<i>e</i>]pyridin-5(1<i>H</i>)-one
C29H22ClN3O
Acta Crystallographica Section C (2011) 67, 12 o479-o483
a=8.1014(5)Å b=11.3554(10)Å c=13.5762(11)Å
α=102.755(7)° β=90.013(8)° γ=108.268(7)°
3-<i>tert</i>-butyl-1-(4-chlorophenyl)-4- (4-methoxyphenyl)indeno[1,2-<i>b</i>]pyrazolo[4,3-<i>e</i>]pyridin-\ 5(1<i>H</i>)-one
C30H24ClN3O2
Acta Crystallographica Section C (2011) 67, 12 o479-o483
a=11.1911(9)Å b=11.4258(8)Å c=20.095(2)Å
α=97.411(6)° β=93.272(7)° γ=107.635(6)°
C72H60Cu4I4P4[solvent]
C72H60Cu4I4P4[solvent]
ACS omega (2020) 5, 46 30148-30159
a=18.3661(16)Å b=16.0719(14)Å c=27.117(3)Å
α=90° β=108.602(10)° γ=90°
C29H31CuIN4P
C29H31CuIN4P
ACS omega (2020) 5, 46 30148-30159
a=10.7747(8)Å b=15.4475(10)Å c=19.6421(12)Å
α=109.743(6)° β=99.759(5)° γ=103.575(6)°
C13H12N4O2
C13H12N4O2
The Journal of organic chemistry (2017) 82, 24 13376-13385
a=11.29659(18)Å b=28.0997(4)Å c=7.63435(10)Å
α=90° β=96.3340(13)° γ=90°
C14H11N3O
C14H11N3O
The Journal of organic chemistry (2018) 83, 18 10887-10897
a=14.466(2)Å b=7.8330(15)Å c=20.727(4)Å
α=90° β=98.549(15)° γ=90°
C23H21N3O4
C23H21N3O4
The Journal of organic chemistry (2017) 82, 23 12674-12681
a=10.0379(13)Å b=10.2812(13)Å c=10.6299(13)Å
α=73.378(11)° β=83.687(10)° γ=80.048(11)°
C26H25ClN4O4
C26H25ClN4O4
The Journal of organic chemistry (2017) 82, 23 12674-12681
a=7.0920(15)Å b=34.990(8)Å c=9.922(3)Å
α=90° β=98.12(3)° γ=90°
C26H25N4O4
C26H25N4O4
The Journal of organic chemistry (2017) 82, 23 12674-12681
a=7.1294(7)Å b=32.835(3)Å c=10.2161(9)Å
α=90° β=96.947(9)° γ=90°
C23H18ClN3O3
C23H18ClN3O3
The Journal of organic chemistry (2017) 82, 23 12674-12681
a=16.130(2)Å b=17.057(3)Å c=15.338(2)Å
α=90° β=106.066(14)° γ=90°
C28H20FN3O3,C3H7NO
C28H20FN3O3,C3H7NO
The Journal of organic chemistry (2017) 82, 23 12674-12681
a=10.8530(15)Å b=12.0931(16)Å c=12.7462(12)Å
α=111.386(10)° β=93.203(10)° γ=111.842(13)°
C10H9N3O
C10H9N3O
The Journal of organic chemistry (2016) 81, 24 12364-12373
a=6.8354(5)Å b=11.3494(10)Å c=12.1390(9)Å
α=90° β=104.352(2)° γ=90°
Methyl 4-(5-amino-3-tert-butyl-1H-pyrazol-1-yl)benzoate
C15H19N3O2
Acta Crystallographica Section C (2007) 63, 1 o21-o25
a=6.1272(2)Å b=11.6374(3)Å c=20.3182(7)Å
α=90.00° β=98.629(2)° γ=90.00°